Using a human SH-SY5Y neuroblastoma cell line overexpressing SNCA, Kao showed that insulin-like growth factor 1 (IGF1) application rescues α-syn toxicity and aggregation [120]. The gene discussed is IGF1; the disease is neuroblastoma.